Am J Transplant, Volume 20, Suppl 3 Archives - Page 57 of 223 - ATC Abstracts

2020 American Transplant Congress
Dual Kidney Transplantation Offers a Safe and Effective Way to Use Kidneys from Deceased Donors Older Than 70 Years
K. Lee, J. Park, S. Cha, M. Kim
Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Dual kidney transplantation (DKT) offers a way to extend the use of kidneys from expanded criteria donors (ECDs). Here, we compared the outcomes of…
2020 American Transplant Congress
Hyperlipidemia Prevalence and Treatment in Pediatric Kidney Transplantation
A. Serluco¹, A. Berganini¹, R. Liverman¹, R. George², R. Garro², P. Winterberg²
¹Children's Healthcare of Atlanta, Atlanta, GA, ²Emory University, Atlanta, GA
*Purpose: Cardiovascular disease (CVD) is the leading cause of mortality in adult survivors of pediatric kidney transplantation. This study describes the prevalence of hyperlipidemia and…
2020 American Transplant Congress
CD38 Antibody Daratumumab for the Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
K. Doberer¹, J. Kläger², G. A. Gualdoni¹, K. Mayer¹, F. Eskandary¹, H. Agis³, T. Reiter¹, R. Reindl-Schwaighofer¹, M. Wahrmann¹, G. Cohen¹, H. Haslacher⁴, G. Bond¹, I. Simonitsch-Klupp⁵, I. Farkash⁶, P. Halloran⁷, G. A. Böhmig¹
¹Department of Medicine III, Medical University of Vienna, Vienna, Austria, ²Dept. of Clin. Pathology, Medical University of Vienna, Vienna, Austria, ³Department of Medicine I, Medical University of Vienna, Vienna, Austria, ⁴Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria, ⁵Department of Pathology, Medical University of Vienna, Vienna, Austria, ⁶Dept. of Pathology, University of Michigan, Ann Arbor, MI, ⁷Alberta Transplant Applied Genomics Centre, ATAGC, University of Alberta, Edmonton, AB, Canada
*Purpose: Late antibody-mediated rejection (ABMR) is a major cause of transplant failure. Potential therapeutic targets are plasma cells (PC) and natural killer (NK) cells expressing…
2020 American Transplant Congress
Long Term Outcomes of Kidney Transplantation in Patients with AL-Amyloidosis – The Mayo Clinic Experience
A. Bentall¹, C. Heybali², J. Wen³, A. Hatem¹, C. A. Schinstock¹, E. Lorenz¹, M. El Ters¹, M. Mai⁴, H. Khamash⁵, D. Murray⁶, M. D. Stegall⁷, F. G. Cosio¹, M. P. Alexander⁶, N. Leung¹
¹Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ²School of Medicine, Dokuz Eylul University, Izmir, Turkey, ³National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing, China, ⁴Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, ⁵Division of Nephrology and Hypertension, Mayo Clinic, Scottsdale, AZ, ⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, ⁷Department of Transplant Surgery, Mayo Clinic, Rochester, MN
*Purpose: New clone-directed therapies and better definition of hematological response criteria allows assessment of post-kidney transplantation outcomes in patients with light-chain (AL) amyloidosis*Methods: Patients with…
2020 American Transplant Congress
Steroid Dependence at 1 Yr in Kidney Transplant Recipients Initiated on Early Steroid Withdrawal Protocol: Associated Risk Factors and Prognosis
M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin, W. Goggins, O. Adebiyi
Indiana University, Indianapolis, IN
*Purpose: Early steroid withdrawal (ESW) has become a stable immunosuppression regimen in the USA with a third of patients now discharged steroid-free immediately post-transplant. However,…
2020 American Transplant Congress
Uncontrolled DCD vs DBD Liver Transplantation in the United States: Is it Safe to Push the Envelope?
R. A. Choudhury¹, D. Yoeli¹, H. Yaffe¹, H. B. Moore¹, G. Hoeltzel², A. Schulick¹, K. D. Conzen¹, J. J. Pomposelli¹, E. A. Pomfret¹, T. L. Nydam¹
¹Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: Uncontrolled donation after cardiac death (uDCD) liver transplantation has been theorized as a potential option to increase the donor pool due to the typical…
2020 American Transplant Congress
Shorter Waiting Time Was Associated with Higher Risk of Recurrence of Hepatocellular Carcinoma in Liver Transplantation
T. Kitajima¹, S. Nagai¹, D. Moonka², S. Yeddula¹, O. Rizzo¹, M. Kavousi¹, R. Salgia², M. Rizzari¹, K. Collins¹, A. Yoshida¹, M. S. Abouljoud¹
¹Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, ²Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI
*Purpose: Liver transplantation (LT) is an established treatment option for hepatocellular carcinoma (HCC). After 6-month waiting rule was implemented, the impact of wait-listing (WL) time…
2020 American Transplant Congress
Early Allograft Dysfunction as a Predictor for Graft and Patient Survival after Liver Transplantation
L. I. Mazilescu, N. Selzner, G. Sapisochin, T. Reichman, M. Bhat, M. Cattral, L. Lilly, I. McGilvray, Z. Galvin, A. Ghanekar, M. Selzner
Multi Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada
*Purpose: Early allograft dysfunction (EAD) after liver transplantation has been associated with long-term reduced graft and patient survival. In this single center cohort study, we…
2020 American Transplant Congress
Factors Associated with High Mortality in Acute on Chronic Liver Failure Patients Admitted to the Intensive Care Unit, Single Center Experience
O. Mendez Guerrero, D. A. Calle Rodas, E. Cervantes Alvarez, E. Alatorre Arenas, J. Perez Escobar, A. Estanes Hernandez, N. Navarro Alvarez, A. Torre
Hepatology and Liver Transplantation Unit, Gastroenterology department, National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico
*Purpose: ACLF is a newly defined syndrome in the background of a chronic liver disease characterized by acute decompensation, organ failure and high mortality at…
2020 American Transplant Congress
The Level of Plasm Donor-Derived Cell-Free DNA in Kidney Transplant Patients with Severe Pneumonia
L. Liu¹, H. Liu², F. Liu², L. Shu², L. Peng¹
¹Xiangyang Hospital No. 2 of Central South University, Changsha, China, ²AlloDx, Shanghai; Suzhou, China
*Purpose: Pulmonary infection is one of the common complications after kidney transplantation. Donor-derived cell-free DNA (ddcfDNA) is a new biomarker to diagnose allograft injury. Currently,…